Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

365 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-02

Study Completion Date

2026-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study explores how psychosocial factors (e.g., chronic stress, depression) may lead to liver disease progression such as liver cirrhosis or liver cancer among Korean American chronic hepatitis B infection patients. Gathering health information over time from Korean Americans with chronic hepatitis B infection may help doctors find better methods of treatment and on-going care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Harms of Hepatocellular Carcinoma Surveillance

NCT03756051

Carcinoma, Hepatocellular

COMPLETED

Evaluation of Patients With Liver Disease

NCT00001971

Hepatitis D Hepatitis C Hepatitis B +1 more

RECRUITING

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

NCT02031913

Chronic Hepatitis B Hepatic Fibrosis Fatty Liver

COMPLETED

Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B

NCT05871749

Hepatic Steatosis Hepatic Fibrosis Chronic Hepatitis b

COMPLETED

CHronic Hepatopathies Associated with ALcohol Consumption and MetAbolic Syndrome

NCT05623150

Non-Alcoholic Fatty Liver Disease Non-Alcoholic Steatohepatitis Alcohol-related Liver Disease +2 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To estimate the prevalence of chronic hepatitis B (CHB) phenotype and liver disease severity at enrollment visit, and model how multiple social-environmental, psychosocial, behavioral, clinical and biological attributes are associated with variation in CHB phenotype and disease severity.

II. To identify how these same attributes are associated with disease progression over time.

SECONDARY OBJECTIVE:

I. To examine the moderating effects of these multi-level factors on the relationship between liver disease progression and adverse liver disease outcome (e.g., hepatocellular carcinoma \[HCC\]), as well as mediating effects of liver disease progression on the relationship between psychosocial factors and liver cancer or death.

EXPLORATORY OBJECTIVE:

I. Using an explanatory mixed methods approach, to understand the care-seeking behaviors, and dynamics of care, within an ethnically concordant liver disease care model, and how these factors may have both direct and mediational effects on adherence, treatment effectiveness, and adverse disease outcomes.

OUTLINE:

Patients participate in interviews over 20-40 minutes and undergo collection of hair samples at baseline and 18-24 months. Patients' medical records are also reviewed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Viral Hepatitis Hepatitis B Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational (interview, biospecimen collection)

Patients participate in interviews over 20-40 minutes and undergo collection of hair samples at baseline and 18-24 months. Patients' medical records are also reviewed.

Interview

Intervention Type OTHER

Participate in interviews

Biospecimen Collection

Intervention Type PROCEDURE

Undergo collection of hair samples

Electronic Health Record Review

Intervention Type OTHER

Medical records are reviewed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interview

Participate in interviews

Intervention Type OTHER

Biospecimen Collection

Undergo collection of hair samples

Intervention Type PROCEDURE

Electronic Health Record Review

Medical records are reviewed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provide signed and dated informed consent form
* Willing to comply with all study procedures and be available for the duration of the study
* Korean-American male or female, age over 18 and older
* CHB Patients who have lab and medical record data (including hepatitis B virus \[HBV\] deoxyribonucleic acid \[DNA\] viral load, hepatitis B virus e Antigen \[HBeAg\] status, and liver enzyme values) exist from 2015 or before

Exclusion Criteria

* Patients who have received a diagnosis of HCC, although they may have been diagnosed with cirrhosis
* Patients who have been diagnosed with other viral infections (hepatitis C virus \[HCV\], human immunodeficiency virus \[HIV\], etc.)
* Patients who have total baldness

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No